Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caitlin Costello

Showing results (1-10 of 58) with videos related to

Pageof 6
Sort By:
Therapeutic Advances in Hematology|January 3, 2017
An update on the role of daratumumab in the treatment of multiple myelomaCaitlin Costello
The Lancet. Haematology|July 23, 2019
The future of checkpoint inhibition in multiple myeloma?Caitlin Costello
Frontiers in Physiology|April 6, 2026
Airway mucus in infectionCaitlin Costello, Susan Birket
Current Hematologic Malignancy Reports|March 16, 2020
Supportive Care in Multiple MyelomaAmy Guzdar, Caitlin Costello
Future Oncology (London, England)|December 9, 2017
Therapy sequencing strategies in multiple myeloma: who, what and why?Caitlin Costello, Joseph R Mikhael
Future Oncology (London, England)|November 28, 2019
Clinical care of chimeric antigen receptor T-cell patients and managing immune-related adverse effects in the ambulatory and hospitalized setting: a reviewPriya Hays, Caitlin Costello, Deepak Asudani
Neuropsychologia|July 13, 2004
Interhemispheric integration during the menstrual cycle: failure to confirm progesterone-mediated interhemispheric decouplingRebecca J Compton, Caitlin Costello, Julia Diepold
Transfusion|May 7, 2021
Optimizing transfusion management of multiple myeloma patients receiving daratumumab-based regimensSamantha Phou, Caitlin Costello, Patricia M Kopko, et al.
Oncology (Williston Park, N.Y.)|February 17, 2017
A 60-Year-Old Man With Progressive Anemia While Receiving Checkpoint Blockade Therapy for Relapsed MyelofibrosisAaron M Goodman, Megan Rust, Caitlin Costello, et al.
Iscience|August 21, 2025
<i>Pseudomonas aeruginosa</i> increases viscoelasticity and decreases transportability of artificial mucusCaitlin Costello, Mikayla Murphree-Terry, Ashley Oden, et al.
Pageof 6

Showing results (1-10 of 58) with videos related to

Sort By:
Pageof 6
Therapeutic Advances in Hematology|January 3, 2017
An update on the role of daratumumab in the treatment of multiple myelomaCaitlin Costello
The Lancet. Haematology|July 23, 2019
The future of checkpoint inhibition in multiple myeloma?Caitlin Costello
Frontiers in Physiology|April 6, 2026
Airway mucus in infectionCaitlin Costello, Susan Birket
Current Hematologic Malignancy Reports|March 16, 2020
Supportive Care in Multiple MyelomaAmy Guzdar, Caitlin Costello
Future Oncology (London, England)|December 9, 2017
Therapy sequencing strategies in multiple myeloma: who, what and why?Caitlin Costello, Joseph R Mikhael
Future Oncology (London, England)|November 28, 2019
Clinical care of chimeric antigen receptor T-cell patients and managing immune-related adverse effects in the ambulatory and hospitalized setting: a reviewPriya Hays, Caitlin Costello, Deepak Asudani
Neuropsychologia|July 13, 2004
Interhemispheric integration during the menstrual cycle: failure to confirm progesterone-mediated interhemispheric decouplingRebecca J Compton, Caitlin Costello, Julia Diepold
Transfusion|May 7, 2021
Optimizing transfusion management of multiple myeloma patients receiving daratumumab-based regimensSamantha Phou, Caitlin Costello, Patricia M Kopko, et al.
Oncology (Williston Park, N.Y.)|February 17, 2017
A 60-Year-Old Man With Progressive Anemia While Receiving Checkpoint Blockade Therapy for Relapsed MyelofibrosisAaron M Goodman, Megan Rust, Caitlin Costello, et al.
Iscience|August 21, 2025
<i>Pseudomonas aeruginosa</i> increases viscoelasticity and decreases transportability of artificial mucusCaitlin Costello, Mikayla Murphree-Terry, Ashley Oden, et al.
Pageof 6